Demand for AI-powered tools to accelerate drug discovery and research ‌has risen across pharmaceutical companies, academic institutions ‌and ⁠biotech firms [File]
\| Photo Credit: REUTERS

OpenAI on Thursday introduced an artificial intelligence model touting ​increased biology knowledge and scientific research capabilities, as ‌the startup deepens its push into the ​life sciences field.

The GPT-Rosalind, ⁠named after 20th-century British scientist Rosalind Franklin, is designed to support research across biochemistry, drug discovery and ‌translational medicine.

Published - April 17, 2026 10:28 am IST